Skip to main content

Disruptive technologies for effectively rehabilitating chronic ambulatory disability


Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder
(stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the % is higher in
Europe. The remaining is the sum of physically disabled by cerebral palsy (14 million), neuromuscular diseases (4 million),
spinal cord injury (paraplegia and quadriplegia, 3 million) and spina bifida (3 million).
Neurological disorders affect the lower motor of the nervous system and share the progressive muscle weakness, which
lead to several walk disability, loss of autonomy and psychosocial consequences. Most therapeutic treatments are limited to
medicines and musculoskeletal rehabilitation programs, which are very expensive and limited to 15-30 min/week
rehabilitation sessions.
Active lifestyle is the most effective measure to restore the physical conditions. But the loss of muscle strength impedes the
ambulatory function. The need is for a device allowing them walking effortlessly and safely in the everyday life activities.
Based on our ARES technology, -the minimal functional unit providing synchronized joints-muscles mobility- Marsi Bionics
has developed powered orthoses for in-house rehabilitation of patients affected by muscle weakness disorders, showing a
product portfolio that covers the needs of a wide range of Neurological Disorders. Marsi products will be commercialized
under renting models allowing patients acquiring it for daily use. This technology will improve these patients life quality and
enlarge life expectancy by avoiding critical health complications of losing walking ability.
Marsi is strengthened by joining with a leading company in the current industrial market, ESCRIBANO. This alliance in the
frame of SME Phase 2 will speed up industrialization, overcome the certification barrier and minimize the time to market. As
a result, we expect to reach above 36M€ turnover in 2023 and 81 generated jobs.

Zaproszenie do składania wniosków


Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie



Wkład UE netto
€ 1 560 930,00
Calle Rue Del Percebe 30
28521 Rivas Vaciamadrid
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finansowanie spoza UE
€ 668 970,00
Comunidad de Madrid Comunidad de Madrid Madrid

Uczestnicy (1)

Podmiot zewnętrzny

Podmiot prawny inny niż podwykonawca, stowarzyszony lub mający inne powiązania prawne z uczestnikiem. Podmiot realizuje prace na podstawie warunków umowy o grant, dostarcza towary lub świadczy usługi związane z działaniem, jednak nie podpisuje umowy o grant. Podmiot zewnętrzny przestrzega zasad i wymogów dotyczących danego uczestnika wynikających z umowy o grant, dotyczących kwalifikowalności kosztów oraz kontroli wydatków.

Wkład UE netto
€ 79 800,00

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.

Avda Punto Es 10 Parque Cientifico Tecnologico
28805 Alcalá De Henares
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finansowanie spoza UE
€ 189 450,00
Comunidad de Madrid Comunidad de Madrid Madrid